Intervention not reported
All‐cause mortality or liver transplantation at two years · infants with biliary atresia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Subgroup analysis of infants operated on at less than 70 days of age who did not clear their jaundice by six months after Kasai portoenterostomy · infants with biliary atresia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Mortality (all‐cause) · patients with chronic obstructive pulmonary disease
It is very uncertain whether once‐daily ICS/LABA combined inhalers changes mortality (all‐cause) compared with once‐daily LAMA (very low certainty).
1 finding from 1 review
Pneumonia · patients with chronic obstructive pulmonary disease
It is very uncertain whether once‐daily ICS/LABA combined inhalers changes pneumonia compared with once‐daily LAMA (very low certainty).
1 finding from 1 review
Quality of life · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Hospital admissions · patients with chronic obstructive pulmonary disease
It is very uncertain whether once‐daily ICS/LABA combined inhalers changes hospital admissions (all‐cause) compared with once‐daily LAMA (very low certainty).
1 finding from 1 review
Exacerbations leading to intubation · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Physical activity measure (e.g. 6MWT) · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Residual pleural fluid on chest X‐ray at 8 weeks · adults and adolescents with pleural TB
The intervention may leads to lower residual pleural fluid on chest X‐ray at 8 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Residual pleural fluid on chest X‐ray at 24 weeks · adults and adolescents with pleural TB
The intervention may leads to lower residual pleural fluid on chest X‐ray at 24 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Pleural changes at the end of · adults and adolescents with pleural TB
The intervention may leads to lower pleural changes at the end of (low certainty).
1 finding from 1 review
Intervention not reported
Long‐term functional respiratory impairment (> 6 months) · adults and adolescents with pleural TB
1 finding from 1 review
Intervention not reported
Adverse events leading to treatment discontinuation ( · adults and adolescents with pleural TB
The intervention may leads to higher adverse events leading to treatment discontinuation ( (low certainty).
1 finding from 1 review
Intervention not reported
HIV‐related infections (cryptococcal meningitis) · adults and adolescents with pleural TB
It is very uncertain whether the intervention changes HIV‐related infections (cryptococcal meningitis) (very low certainty).
1 finding from 1 review
Intervention not reported
HIV‐related cancer (Kaposi's sarcoma) · adults and adolescents with pleural TB
It is very uncertain whether the intervention changes HIV‐related cancer (Kaposi's sarcoma) (very low certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · very low birth weight preterm neonates
Early inhaled steroids (< 2 weeks) showed no clear difference in CLD at 36 weeks' PMA oxygen dependency at 36 weeks' PMA compared with placebo (among all randomised) (moderate certainty).
1 finding from 1 review
Death by, or CLD at, 36 weeks' PMA Death or oxygen dependency at 36 weeks' PMA · very low birth weight preterm neonates
Early inhaled steroids (< 2 weeks) probably leads to lower death by, or CLD at, 36 weeks' PMA Death or oxygen dependency at 36… compared with placebo (among all randomised) (moderate certainty).
1 finding from 1 review
CLD at 36 weeks' PMA · very low birth weight preterm neonates
Early inhaled steroid (< 2 weeks) probably leads to lower CLD at 36 weeks' PMA compared with placebo (among survivors) (moderate certainty).
1 finding from 1 review
Death or bronchopulmonary dysplasia at 36 weeks PMA · Neonates with developing BPD
Inhaled steroids showed no clear difference in death or BPD at 36 weeks' postmenstrual age compared with systemic steroids (moderate certainty).
2 findings from 1 review
Diastolic blood pressure > 95th percentile at 7 years · Neonates with developing BPD
Inhaled steroids probably leads to lower diastolic blood pressure > 95th percentile at 7 years compared with systemic steroids (moderate certainty).
1 finding from 1 review